Regenerative pharmacology in the treatment of genetic diseases: The paradigm of muscular dystrophy
- 2 September 2008
- journal article
- review article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 41 (4) , 701-710
- https://doi.org/10.1016/j.biocel.2008.08.033
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Muscular atrophy of caveolin-3–deficient mice is rescued by myostatin inhibitionJournal of Clinical Investigation, 2006
- Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathwayOncogene, 2006
- Regulation and Function of IKK and IKK-Related KinasesScience's STKE, 2006
- Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist GremlinThe Journal of cell biology, 2006
- Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitorsNature Medicine, 2006
- Molecular mechanisms of muscular dystrophies: old and new playersNature Reviews Molecular Cell Biology, 2006
- Muscle stem cells in development, regeneration, and diseaseGenes & Development, 2006
- Stem cells, ageing and the quest for immortalityNature, 2006
- Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cellsNature Cell Biology, 2006
- Age-Dependent Effect of Myostatin Blockade on Disease Severity in a Murine Model of Limb-Girdle Muscular DystrophyThe American Journal of Pathology, 2006